Funding News | NIH: National Institute of Allergy and Infectious Diseases

Funding News | NIH: National Institute of Allergy and Infectious Diseases

April 17, 2019 NIAID Funding News

Read this full issue online at http://www.niaid.nih.gov/grants-contracts/funding-news-notices

Feature Articles 

Tips for Writing a Strong Multiple PI Leadership Plan

Reviewers will judge the Leadership Plan of an application with multiple principal investigators (PIs) for its scientific merit and whether it promotes enough coordination and communication among PIs.

Opportunities and Resources

New BAA on Developing Vaccines for Treating Opioid Use Disorder

Through a broad agency announcement (BAA), NIAID seeks contract proposals to develop anti-opioid vaccines to protect against the effects of heroin and fentanyl.

Wanted: Innovative Informatics Approaches to Immunology

NIAID plans to fund contributors proposing new analytical approaches to immunology data within the Immunology Database and Analysis Portal (ImmPort).

Consider Two Atopic Dermatitis Research Network Opportunities

Get research support to study differences in skin structure, skin function, and immune responses between patients with atopic dermatitis and healthy individuals or disease controls.

In The News

Another Sample R01 Application for You

Our Sample Applications & More page has a new R01 sample application and summary statement for you to check out.

Reminders for May 7 Due Date for AIDS-Related Applications

Always choose a funding opportunity announcement that includes the standard due date corresponding to the Advisory Council round you’re targeting.

Find an NIAID Area of Interest in an NIH NOSI

A recent notice of special interest (NOSI) calls for research on the biological, clinical, behavioral, and social processes that affect the health and development of sexual and gender minority populations.

Advice Corner

Don’t Be Fazed by Multiple Meanings of “Phase”

NIH uses the word "phase" in several contexts, including when referring to clinical trials, phased awards, and small business grant award programs.

Reader Questions

• “Can a consultant act as principal investigator (PI) on a grant or must the PI be a direct employee of the applicant organization?”
• “What is the page limit for letters of support included in a Small Business Innovation Research–Phase I (R43) application?”

New Funding Opportunities

• RFA-AI-19-030, Feasibility of Novel Diagnostics for TB in Endemic Countries (FEND for TB) (U01, Clinical Trial Not Allowed)
• PAR-19-248, Research Projects to Improve the Predictive Value of Animal Models in Recapitulating Human Immunity to Influenza Infection and Vaccination (R01, Clinical Trial Not Allowed)
• PAR-19-247, Research Projects to Improve the Predictive Value of Animal Models in Recapitulating Human Immunity to Influenza Infection and Vaccination (R21, Clinical Trial Not Allowed)
• PAR-19-244, International Research Ethics Education and Curriculum Development Award (R25, Clinical Trial Not Allowed)
• RFA-OD-19-020, Building Interdisciplinary Research Careers in Women's Health (BIRCWH) (K12, Clinical Trial Optional)
• PA-19-217, Administrative Supplement for Research on Bioethical Issues (Admin Supp, Clinical Trial Optional)

See other announcements at Opportunities & Announcements.

Send suggestions or comments to deaweb@niaid.nih.gov.